RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
29.60
-0.73 (-2.41%)
Feb 21, 2025, 4:00 PM EST - Market closed
RxSight Employees
RxSight had 374 employees as of December 31, 2023. The number of employees increased by 82 or 28.08% compared to the previous year.
Employees
374
Change (1Y)
82
Growth (1Y)
28.08%
Revenue / Employee
$343,029
Profits / Employee
-$82,070
Market Cap
1.19B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 374 | 82 | 28.08% |
Dec 31, 2022 | 292 | 71 | 32.13% |
Dec 31, 2021 | 221 | 50 | 29.24% |
Dec 31, 2020 | 171 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RXST News
- 5 weeks ago - RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - GlobeNewsWire
- 7 weeks ago - RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye - Seeking Alpha
- 3 months ago - RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 - GlobeNewsWire
- 6 months ago - RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences - GlobeNewsWire
- 6 months ago - Investing In The Future Of Cataract Surgery: The RxSight Advantage - Seeking Alpha
- 7 months ago - RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript - Seeking Alpha